Lin Esther R-H, Veenker Faith N, Manza Peter, Yonga Michele-Vera, Abey Sarah, Wang Gene-Jack, Volkow Nora D
Laboratory of Neuroimaging, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892, USA.
Brain Sci. 2024 Dec 21;14(12):1285. doi: 10.3390/brainsci14121285.
Substance use disorders (SUDs) and anxiety disorders (ADs) are highly comorbid, a co-occurrence linked to worse clinical outcomes than either condition alone. While the neurobiological mechanisms involved in SUDs and anxiety disorders are intensively studied separately, the mechanisms underlying their comorbidity remain an emerging area of interest. This narrative review explores the neurobiological processes underlying this comorbidity, using the Research Domain Criteria (RDoC) framework to map disruptions in positive valence, negative valence, and cognitive systems across the three stages of the addiction cycle: binge/intoxication, withdrawal/negative affect, and preoccupation/anticipation. Anxiety and substance use play a reciprocal role at each stage of addiction, marked by significant psychosocial impairment and dysregulation in the brain. A more thorough understanding of the neural underpinnings involved in comorbid SUDs and anxiety disorders will contribute to more tailored and effective therapeutic interventions and assessments.
物质使用障碍(SUDs)和焦虑症(ADs)高度共病,这种共病与比单独任何一种疾病更差的临床结果相关。虽然对物质使用障碍和焦虑症所涉及的神经生物学机制分别进行了深入研究,但它们共病的潜在机制仍是一个新兴的研究领域。本叙述性综述利用研究领域标准(RDoC)框架,探讨了这种共病背后的神经生物学过程,以描绘成瘾周期三个阶段( binge/中毒、戒断/消极情绪、专注/预期)中积极效价、消极效价和认知系统的破坏情况。焦虑和物质使用在成瘾的每个阶段都起着相互作用,其特征是明显的心理社会损害和大脑失调。对共病的物质使用障碍和焦虑症所涉及的神经基础有更全面的了解,将有助于制定更有针对性和有效的治疗干预措施及评估方法。